Isopimaric acid from Pinus nigra shows activity against multidrug-resistant and EMRSA strains of Staphylococcus aureus

被引:104
|
作者
Smith, E [1 ]
Williamson, E [1 ]
Zloh, M [1 ]
Gibbons, S [1 ]
机构
[1] Univ London, Sch Pharm, Ctr Pharmacognosy & Phytotherapy, London WC1N 1AX, England
关键词
isopimaric acid; Staphylococcus aureus; MRSA; EMRSA; multidrug-resistance; MDR; efflux;
D O I
10.1002/ptr.1711
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The diterpene isopimaric acid was extracted from the immature cones of Pinus nigra (Arnold) using bioassay. guided fractionation of a crude hexane extract. Isopimaric acid was assayed against multidrug-resistant (MDR) and methicillin-resistant Staphylococcus aureus (MRSA). The minimum inhibitory concentrations (MIC) were 32-64 mu g/mL and compared with a commercially obtained resin acid, abietic acid, with MICs of 64 mu g/mL. Resin acids are known to have antibacterial activity and are valued in traditional medicine for their antiseptic properties: These results show that isopimaric acid is active against MDR an MRSA strains of S. aureus which are becoming, increasingly resistant to antibiotics. Both compounds were evaluated for modulation activity in combination with antibiotics, but did not potentiate the activity of the antibiotics tested. However, the compounds were also assayed in combination with the efflux pump inhibitor reserpine, to ice if inhibition of the TetK or NorA efflux pump increased their activity. Interestingly, rather than a potentiation of activity by a reduction in MIC, a two to four-fold increase in MIC was seen. It may he that isopimaric acid and abietic acid are not substrates for these efflux pumps, but it is also possible that an antagonistic interaction with reserpine may render the antibiotics inactive. H-1-NMR of abietic acid and reserpine taken individually and in combination, revealed a shift in resonance of some peaks for both compounds when mixed together compared with the spectra of the compounds on their own. It is proposed that this may he due to complex formation between abietic acid and reserpine and that this complex formation is responsible for a reduction in activity and elevation of MIC. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:538 / 542
页数:5
相关论文
共 50 条
  • [21] Biocompatible, antibacterial, polymeric hydrogels active against multidrug-resistant Staphylococcus aureus strains for food packaging applications
    Narayanan, Kannan Badri
    Park, Gyu Tae
    Han, Sung Soo
    FOOD CONTROL, 2021, 123
  • [22] Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus
    Lin, Ming-Ching
    Hui, Cho-Fat
    Chen, Jyh-Yih
    Wu, Jen-Leih
    PEPTIDES, 2013, 44 : 139 - 148
  • [23] New Synergistic Combination Therapy of Mupirocin and α-Pinene Against Multidrug-Resistant Clinical Strains of Methicillin-Resistant Staphylococcus aureus
    Caceres-Guido, Paulo
    Martin-Vazquez, Nicolas
    Ojeda-Sana, Adriana
    van Baren, Catalina
    Balbarrey, Ziomara
    Moreno, Silvia
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2024, 43 (02) : 73 - 78
  • [24] Activity of Debio1452, a FabI Inhibitor with Potent Activity against Staphylococcus aureus and Coagulase-Negative Staphylococcus spp., Including Multidrug-Resistant Strains
    Flamm, Robert K.
    Rhomberg, Paul R.
    Kaplan, Nachum
    Jones, Ronald N.
    Farrell, David J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (05) : 2583 - 2587
  • [25] Furan fatty acid, EODA: A new candidate for antibacterial agent against multidrug-resistant Staphylococcus aureus
    Dasagrandhi, C.
    Kim, H. R.
    NEW BIOTECHNOLOGY, 2018, 44 : S156 - S156
  • [26] Metabolites of the "Smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus
    Belofsky, G
    Carreno, R
    Lewis, K
    Ball, A
    Casadei, G
    Tegos, GP
    JOURNAL OF NATURAL PRODUCTS, 2006, 69 (02): : 261 - 264
  • [27] Endophytic Fungi Isolated from Ageratina adenophora Exhibits Potential Antimicrobial Activity against Multidrug-Resistant Staphylococcus aureus
    Wen, Juan
    Okyere, Samuel Kumi
    Wang, Jianchen
    Huang, Ruya
    Wang, Ya
    Liu, Lin
    Nong, Xiang
    Hu, Yanchun
    PLANTS-BASEL, 2023, 12 (03):
  • [28] Rapid Bactericidal Activity of SC5005 Combined with Docosahexaenoic Acid against Multidrug-Resistant Staphylococcus aureus Persisters and Biofilms
    Yeo, Hui-Hui
    Shiau, Chung-Wei
    Jao, Yu-Hsuan
    Wan, Tsai-Wen
    Chiu, Hao-Chieh
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (12)
  • [29] SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of staphylococcus aureus and enterococcus
    Muto, CA
    Jernigan, JA
    Ostrowsky, BE
    Richet, HM
    Jarvis, WR
    Boyce, JM
    Farr, BM
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (05): : 362 - 386
  • [30] Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci
    Smith, Jordan R.
    Yim, Juwon
    Raut, Animesh
    Rybak, Michael J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (04) : 2352 - 2358